Expression of Cox-1 and Cox-2 in Canine Mammary Tumours

Journal of Comparative Pathology

Volumn 136, Issue 2-3, 2007, Pages 177-185

  Queiroga, F L ^a   Alves, A ^c   Pires, I ^c   Lopes, C ^b  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c NONE

Author keywords

Cox 1 and 2; cyclooxygenase; dog; mammary tumours; tumours

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BENIGN TUMOR; BREAST ADENOMA; BREAST TUMOR; CARCINOMA IN SITU; CARCINOSARCOMA; CONTROLLED STUDY; DOG; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADENOMA; ANIMALS; CARCINOSARCOMA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOENZYME TECHNIQUES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL;

CANIS FAMILIARIS;

EID: 34047246502     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2007.01.010     Document Type: Article

References (45)

1. Bauer A.K., Dwyer-Nield L.D., and Malkinson A.M. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumours. Carcinogenesis 21 (2000) 543-550
2. Beam S.L., Rassnick K.M., Moore A.S., and McDonough S.P. An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Veterinary Pathology 40 (2003) 496-500
3. Boland G.P., Butt I.S., Prasad R., Knox W.F., and Bundred N.J. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. British Journal of Cancer 90 (2004) 423-429
4. Borzacchiello G., Ambrosio V., Galato P., Perillo A., and Roperto F. Cyclooxygenase-1 and -2 expression in urothelial carcinomas of the urinary bladder in cows. Veterinary Pathology 40 (2003) 455-459
5. Costa C., Soares R., Reis-Filho J.S., Leitão D., Amendoeira I., and Schmitt F.C. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. Journal of Clinical Pathology 55 (2002) 429-434
6. Dang C.T., Shapiro C.L., and Hudis C.A. Potential role of selective COX-2 inhibitors in cancer management. Oncology 16 (2002) 30-36
7. Davies G., Martin L.A., Sacks N., and Dowsett M. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Annals of Oncology 13 (2002) 669-678
8. Denkert C., Winzer K.J., and Hauptmann S. Prognostic impact of cyclooxygenase-2 in breast cancer. Clinical Breast Cancer 4 (2004) 428-433
9. Doré M., Lanthier I., and Sirois J. Cyclooxygenase-2 expression in canine mammary tumours. Veterinary Pathology 40 (2003) 207-212
10. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. FASEB Journal 12 (1998) 1063-1073
11. Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Annals of Clinical and Laboratory Science 30 (2000) 3-21
12. Half E., Tang X.M., Gwyn K., Sahin A., Wathen K., and Sinicrope F.A. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Research 62 (2002) 1676-1681
13. Harris R.E., Alshafie G.A., Abou-Issa H., and Seibert K. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Research 60 (2000) 2101-2103
14. Harris R.E., Kasbari S., and Farrar W.B. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncology Reports 6 (1999) 71-73
15. Hazar B., Ergin M., Seyrek E., Erdogan S., Tuncer I., and Hakverdi S. Cyclooxygenase-2 (Cox-2) expression in lymphomas. Leukemia & Lymphoma 45 (2004) 1395-1399
16. Hla T., Bishop-Bailey D., Liu C.H., Schaefers H.J., and Trifan O.C. Cyclooxygenase-1 and -2 isoenzymes. International Journal of Biochemistry & Cell Biology 31 (1999) 551-557
17. Howe L.R., Subbaramaiah K., Brown A.M., and Dannenberg A.J. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocrine Related Cancer 8 (2001) 97-114
18. Hwang D., Scollard D., Byrne J., and Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. Journal of the National Cancer Institute 90 (1998) 455-460
19. Khan K., Knapp D., Denicola D., and Harris R. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. American Journal of Veterinary Research 61 (2000) 478-481
20. Kirkpatrick K., Ogunkolade W., Elkak A., Bustin S., Jenkins P., Ghilchik M., and Mokbel K. The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Current Medical Research and Opinion 18 (2002) 237-241
21. Kleiter M., Malarkey D.E., Ruslander D.E., and Thrall D.E. Expression of cyclooxygenase-2 in canine epithelial nasal tumours. Veterinary Radiology & Ultrasound 45 (2004) 255-260
22. Knapp D.W., Glickman N.W., Mohammed S.I., DeNicola D.B., Widmer W.R., Bonney P.L., and DeGortari A.E. Antitumour effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer. Advances in Experimental Medicine and Biology 507 (2002) 377-380
23. Knapp D.W., Richardson R.C., Chan T.C., Bottoms G.D., Widmer W.R., DeNicola D.B., Teclaw R., Bonney P.L., and Kuczek T. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. Journal of Veterinary Internal Medicine 8 (1994) 273-278
24. Lee C.H., Kim W.H., Lim J.H., Kang M.S., Kim D.Y., and Kweon O.K. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumours. Journal of Veterinary Science 5 (2004) 63-69
25. Liu C.H., Chang S.H., Narko K., Trifan O.C., Wu M.T., Smith E., Haudenschild C., Lane T.F., and Hla T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. Journal of Biological Chemistry 276 (2001) 18563-18569
26. McEntee M.F., Cates J.M., and Neilsen N. Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Veterinary Pathology 39 (2002) 428-436
27. Misdorp, W. (2002). Tumours of the mammary gland. In: Tumours in Domestic Animals. 4th Edit., D.J. Meuten, Ed., Iowa State Press, Iowa, USA, pp. 575-606.
28. Misdorp, W., Else, R.W., Hellmén, E. and Lipscomb, T.P. (1999). Histological Classification of Mammary Tumours of the Dog and the Cat, 2nd series, Vol. VII, Armed Forces Institute of Pathology, American Registry of Pathology, Washington, DC, and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, pp. 1-59.
29. Mohammed S.I., Khan K.N., Sellers R.S., Hayek M.G., DeNicola D.B., Wu L., Bonney P.L., and Knapp D.W. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins Leukotrienes and Essential Fatty Acids 70 (2004) 479-483
30. Moran E.M. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. Journal of Environmental Pathology, Toxicology and Oncology 21 (2002) 193-201
31. Morita I., Schindler M., Regier M.K., Otto J.C., Hori T., DeWitt D.L., and Smith W.L. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. Journal of Biological Chemistry 270 (1995) 10902-10908
32. Parfenova H., Parfenov V.N., Shlopov B.V., Levine V., Falkos S., Pourcyrous M., and Leffler C.W. Dynamics of nuclear localization sites for Cox-2 in vascular endothelial cells. American Journal of Physiology-Cell Physiology 281C (2001) 166-178
33. Pena L.L., Nieto A.I., Pérez-Alenza D., Cuesta P., and Castano M. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumours: relationship to clinical and pathologic variables. Journal of Veterinary Diagnostic Investigation 10 (1998) 237-246
34. Perez-Alenza M.D., Pena L., del Castillo N., and Nieto A.I. Factors influencing the incidence and prognosis of canine mammary tumours. Journal of Small Animal Practice 41 (2000) 287-291
35. Pestili de Almeida E., Piche C., Sirois J., and Doré M. Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. Journal of Histochemistry and Cytochemistry 49 (2001) 867-875
36. Ristimaki A., Nieminen O., Saukkonen K., Hotakainen K., Nordling S., and Haglund C. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. American Journal of Pathology 158 (2001) 849-853
37. Sarli G., Preziosi R., Benazzi C., Castellani G., and Marcato P.S. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumours. Journal of Veterinary Diagnostic Investigation 14 (2002) 25-34
38. Shim V., Gauthier M.L., Sudilovsky D., Mantei K., Chew K.L., Moore D.H., Cha I., Tlsty T.D., and Esserman L.J. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium. Cancer Research 63 (2003) 2347-2350
39. Sorenmo K. Canine mammary gland tumours. Veterinary Clinics of North America: Small Animal Practice 33 (2003) 573-596
40. Soslow R.A., Dannenberg A.J., Rush D., Woerner B.M., Khan K.N., Masferrer J., and Koki A.T. COX-2 is expressed in human pulmonary, colonic, and mammary tumours. Cancer 89 (2000) 2637-2645
41. Sucic M., Boban D., Markovic-Glamocak M., Jakic-Razumovic J., Vrbanec D., Ries S., Gjadrov-Kuvezdic K., Cobanov A.M., Podolski P., Martinovic I., Erak V., Budisic Z., Ivrlac R., and Unusic J. Expression of cyclooxygenase-2 in fine-needle aspirates from breast carcinoma and benign breast diseases. Breast 12 (2003) 51-57
42. Williams C.S., and DuBois R.N. Prostaglandin endoperoxide synthase: why two isoforms?. American Journal of Physiology 270 (1996) 393-400
43. Wilson J.E., Chandrasekharan N.V., Westover K.D., Eager K.B., and Simmons D.L. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. American Journal of Veterinary Research 65 (2004) 810-818
44. Yamagami T., Kobayashi T., Takahashi K., and Sugiyama M. Prognosis for canine malignant mammary tumours based on TNM and histologic classification. Journal of Veterinary Medical Science 58 (1996) 1079-1083
45. Yoshimura N., Sano H., Okamoto M., Akioka K., Ushigome H., Kadotani Y., Yoshimura R., Nobori S., Higuchi A., Ohmori Y., and Nakamura K. Expression of cyclooxygenase-1 and -2 in human breast cancer. Surgery Today 33 (2003) 805-811